Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ+/CD19+-depleted grafts-Reference-Cited by-同舟云学术

Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ+/CD19+-depleted grafts

Published:2018-02-05 Issue:3 Volume:2 Page:263-270
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Gaziev Javid¹,Isgrò Antonella¹,Sodani Pietro²,Paciaroni Katia¹,De Angelis Gioia¹,Marziali Marco¹,Ribersani Michela¹,Alfieri Cecilia¹,Lanti Alessandro³,Galluccio Tiziana¹,Adorno Gaspare³,Andreani Marco¹

Affiliation:

1. International Center for Transplantation in Thalassemia and Sickle Cell Anemia, Mediterranean Institute of Hematology, Policlinico Tor Vergata, Rome, Italy;

2. Unità Operativa Complessa Internal Medicine and Hematology, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Ospedale Santo Croce, Fano, Italy; and

3. Servizio di Immunoematologia e Medicina Trasfusionale, Policlinico Tor Vergata Foundation, Rome, Italy

Abstract

Key Points TCRαβ+/CD19+-depleted haplo-HCT is associated with a reduced incidence of graft failure in patients with hemoglobinopathies. The major challenges of haplo-HCT in hemoglobinopathies are delayed immune reconstitution and associated morbidity and mortality.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/2/3/263/880049/advances012005.pdf

Reference38 articles.

1. Advances in the allogeneic transplantation for thalassemia;Lucarelli;Blood Rev,2008

2. A trial of unrelated donor marrow transplantation for children with severe sickle cell disease;Shenoy;Blood,2016

3. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry;Gragert;N Engl J Med,2014

4. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype;Aversa;N Engl J Med,1998

5. Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide;Robinson;Semin Hematol,2016

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Follow-Up of Abatacept, Post-Transplantation Cyclophosphamide, and Sirolimus-Based Haploidentical Transplantation in Younger Patients with Nonmalignant Diseases;Transplantation and Cellular Therapy;2024-06

2. Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation;Cells;2024-01-11

3. The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally;Hematology;2023-12-08

4. Sickle cell disease: combination new therapies vs. CRISPR-Cas9 potential and challenges — review article;Annals of Hematology;2023-10-23

5. Autoimmune cytopenias following pediatric hematopoietic cell transplant;Bone Marrow Transplantation;2023-10-04